Psychedelics Flashcards
Describe how the relationship between serotonergic psychedelic / MDMA
administration and non-drug therapeutic approaches differs from other
approaches for PTSD and MDD
What receptor do psychedelics bind to?
-5-HT2A agonist
-many targets but that is the big one
MDMA MOA
-reversal of VMAT2: increase intracellular 5-HT
-Reversal of 5-HT through SERT
-Substrate / Releaser at
monoamine transporters (SERT
/ NET/ DAT)
Metabolism of LSD
-metabolized by CYP2D6
-a little by 3A4, 1A2, 2C9, 2E1
Common dose of LSD
100-200 mcg
-elimination half life: 2.6 +/- 0.6 h
-subjective Effect Duration (200 mcg): 11.6 ±
1.7 h
Metabolism of Psilocybin
-undergos glucuronidation and other metabolism enzymes
-MAO-A
-UGT1A10 and 1A9
aldehyde dehydrogenase
-Few drug interactions
Metaboloism of DMT
-CYP2D6 and MAO-A
-little 2C19
DMT dose range
-0.1-0.4 mg/kg IV
-30-50 mg inhaled
-Elimination half life 9-12 minutes
-Effect duration: 25 minutes
Metabolism of 5-MeO-DMT
-CYP2D6 and MAO-A
Metabolism of MDMA
-CYP2D6
-CYP3A4
-MAO-A
-COMT
-most likely to cause drug interactions
Common MAO inhibitors
-Selegiline
-Tranylcypromine
-Isocarboxazid
Common strong CYP2D6 inhibitors
-Bupropion
-Fluoxetine
-Paroxetine
-Quinidine
-Terbinafine
Common moderate CYP2D6 inhibitors
-Duloxetine
-Cinacalcet
-Mirabegron
-Rolapitant
Common weak CYP2D6 inhibitors
-Escitalopram
-Fluvoxamine
-Sertraline
Haloperidol and psilocybin
-no effect
-increase the ‘dread of ego dissolution’: made them scared
Risperidone and psilocybin
-reduced all the parameters of the APZ-OAV
-reduction in dread of ego
dissolution
Lithium and psychedelics
-47% of lithium + psychedelics reports involved seizures
-serious seizure risk for this combo
Drug interactions with MDMA
-MAOIs and MDMA
-dangerous elevation in synaptic serotonin
-causes most deaths
Bupropion and MDMA
-increase risk of seizure
-stimulant toxicity
-Serotonin syndrome
(Citalopram, fluoxetine, paroxetine) and MDMA
-increase drug effects by 30-80%
-physiological effects increase 6-14%
Duloxetine and MDMA
-increase heart rate and BP
-effect on mood was significantly reduced by duloxetine
Chronic Psychedelic Use and Drug-
Induced Valvular Heart Disease
Considerations
-chronic 5-HT2B agonism is a concern with microdosing